JP2020513759A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513759A5 JP2020513759A5 JP2019534413A JP2019534413A JP2020513759A5 JP 2020513759 A5 JP2020513759 A5 JP 2020513759A5 JP 2019534413 A JP2019534413 A JP 2019534413A JP 2019534413 A JP2019534413 A JP 2019534413A JP 2020513759 A5 JP2020513759 A5 JP 2020513759A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- substantially similar
- sequence
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662438949P | 2016-12-23 | 2016-12-23 | |
| US62/438,949 | 2016-12-23 | ||
| PCT/US2017/068368 WO2018119474A2 (en) | 2016-12-23 | 2017-12-23 | Immunotherapy using antibodies that bind programmed death 1 (pd-1) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513759A JP2020513759A (ja) | 2020-05-21 |
| JP2020513759A5 true JP2020513759A5 (https=) | 2021-02-04 |
| JP7122758B2 JP7122758B2 (ja) | 2022-08-22 |
Family
ID=62627200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534413A Active JP7122758B2 (ja) | 2016-12-23 | 2017-12-23 | プログラム死－１（ｐｄ－１）に結合する抗体を使用する免疫療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11248049B2 (https=) |
| EP (1) | EP3559044A4 (https=) |
| JP (1) | JP7122758B2 (https=) |
| CN (1) | CN110366564B (https=) |
| RU (1) | RU2768404C2 (https=) |
| WO (1) | WO2018119474A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109843327B (zh) | 2016-07-07 | 2022-05-13 | 小利兰·斯坦福大学托管委员会 | 抗体佐剂缀合物 |
| WO2020190725A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| WO2020259536A1 (zh) | 2019-06-24 | 2020-12-30 | 南京金斯瑞生物科技有限公司 | 单克隆抗体-细胞因子融合蛋白二聚体及其应用 |
| JP6881658B2 (ja) | 2019-07-05 | 2021-06-02 | 小野薬品工業株式会社 | Ｐｄ−１／ｃｄ３二重特異性タンパク質による血液がん治療 |
| US20220332825A1 (en) | 2019-08-08 | 2022-10-20 | Ono Pharmaceutical Co., Ltd. | Bispecific protein |
| WO2021063201A1 (zh) * | 2019-09-30 | 2021-04-08 | 四川科伦博泰生物医药股份有限公司 | 抗pd-1抗体及其用途 |
| MX2023005386A (es) * | 2020-11-11 | 2023-05-23 | BioNTech SE | Anticuerpos monoclonales dirigidos contra la proteina de muerte programada-1 y su uso en medicina. |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101899114A (zh) * | 2002-12-23 | 2010-12-01 | 惠氏公司 | 抗pd-1抗体及其用途 |
| DK2439273T3 (da) * | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| RU2423381C2 (ru) * | 2005-07-25 | 2011-07-10 | Трабьон Фармасьютикалз, Инк. | Снижение количества в-клеток с использованием cd37-специфических и cd20-специфических связывающих молекул |
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| KR101523391B1 (ko) * | 2006-12-27 | 2015-05-27 | 에모리 유니버시티 | 감염 및 종양 치료를 위한 조성물 및 방법 |
| BR122017025062B8 (pt) | 2007-06-18 | 2021-07-27 | Merck Sharp & Dohme | anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento |
| EP2262837A4 (en) | 2008-03-12 | 2011-04-06 | Merck Sharp & Dohme | PD-1 BINDING PROTEINS |
| BR112014024023A2 (pt) * | 2012-03-28 | 2017-07-18 | Genentech Inc | anticorpos idiotípicos anti-hcmv e usos dos mesmos |
| EP2906596B1 (en) * | 2012-10-12 | 2023-12-27 | Arizona Board of Regents on behalf of Arizona State University | Antibody based reagents that specifically recognize toxic oligomeric forms of tau |
| SMT202100065T1 (it) * | 2013-05-02 | 2021-03-15 | Anaptysbio Inc | Anticorpi diretti contro la proteina della morte programmata (pd-1) |
| CN104250302B (zh) | 2013-06-26 | 2017-11-14 | 上海君实生物医药科技股份有限公司 | 抗pd‑1抗体及其应用 |
| US9629801B2 (en) * | 2014-01-10 | 2017-04-25 | Wisconsin Alumni Research Foundation | Blood-brain barrier targeting antibodies |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| FI128317B (fi) | 2014-07-03 | 2020-03-13 | Serres Oy | Tyhjennyslaite, kokoonpano ja menetelmä imupussin tyhjentämiseksi |
| BR112017001385B1 (pt) * | 2014-07-22 | 2023-12-05 | Cb Therapeutics, Inc. | Anticorpo isolado ou fragmento do mesmo que liga a pd-1, uso deste, composição, polinucleotídeo isolado e vetor de expressão |
| EP3218409A2 (en) * | 2014-11-11 | 2017-09-20 | Sutro Biopharma, Inc. | Anti-pd-1 antibodies, compositions comprising anti-pd-1 antibodies and methods of using anti-pd-1 antibodies |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| TWI595006B (zh) * | 2014-12-09 | 2017-08-11 | 禮納特神經系統科學公司 | 抗ｐｄ－１抗體類和使用彼等之方法 |
| DK3237446T3 (en) * | 2014-12-22 | 2021-07-26 | Pd 1 Acquisition Group Llc | Anti-PD-1-antistoffer |
| TW201710286A (zh) * | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | 抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白 |
| CN106008714B (zh) * | 2016-05-24 | 2019-03-15 | 瑞阳(苏州)生物科技有限公司 | 抗人pd-1人源化单克隆抗体及其应用 |
-
2017
- 2017-12-23 RU RU2019121106A patent/RU2768404C2/ru active
- 2017-12-23 WO PCT/US2017/068368 patent/WO2018119474A2/en not_active Ceased
- 2017-12-23 CN CN201780087512.8A patent/CN110366564B/zh active Active
- 2017-12-23 JP JP2019534413A patent/JP7122758B2/ja active Active
- 2017-12-23 EP EP17883242.4A patent/EP3559044A4/en not_active Withdrawn
- 2017-12-23 US US16/472,685 patent/US11248049B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020514277A5 (https=) | ||
| JP2020513759A5 (https=) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2020508655A5 (https=) | ||
| JP2022031635A5 (https=) | ||
| JP7257971B6 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| JP2022533538A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2021533726A5 (https=) | ||
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| JP2017149720A5 (https=) | ||
| RU2019121106A (ru) | Иммунотерапия с применением антител, связывающих белок 1 программируемой смерти клеток (pd-1) | |
| JP2015163068A5 (https=) | ||
| JP2015503909A5 (https=) | ||
| JP2018510617A5 (https=) | ||
| JP2018522888A5 (https=) | ||
| JP7679399B2 (ja) | 抗ｆｌｔ３抗体及び組成物 | |
| JP2020502233A5 (https=) | ||
| US12173081B2 (en) | CD19/CD38 multispecific antibodies | |
| JP2021511387A5 (https=) | ||
| JP2024540148A5 (https=) | ||
| JP2019505477A5 (https=) | ||
| JP2016518333A5 (https=) | ||
| JP2020531003A5 (https=) | ||
| JP2022517216A5 (https=) |